Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maase (MAAS) Cash & Equivalents (2018 - 2025)

Maase (MAAS) has disclosed Cash & Equivalents for 7 consecutive years, with $40.8 million as the latest value for Q2 2024.

  • On a quarterly basis, Cash & Equivalents rose 73.94% to $40.8 million in Q2 2024 year-over-year; TTM through Jun 2024 was $40.8 million, a 73.94% increase, with the full-year FY2024 number at $41.0 million, up 80.92% from a year prior.
  • Cash & Equivalents was $40.8 million for Q2 2024 at Maase, up from $23.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $40.8 million in Q2 2024 to a low of $23.5 million in Q2 2023.
  • A 5-year average of $34.9 million and a median of $40.3 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: dropped 27.32% in 2020, then surged 73.94% in 2024.
  • Maase's Cash & Equivalents stood at $40.4 million in 2020, then decreased by 0.06% to $40.3 million in 2021, then dropped by 26.95% to $29.5 million in 2022, then decreased by 20.29% to $23.5 million in 2023, then skyrocketed by 73.94% to $40.8 million in 2024.
  • Per Business Quant, the three most recent readings for MAAS's Cash & Equivalents are $40.8 million (Q2 2024), $23.5 million (Q2 2023), and $29.5 million (Q2 2022).